Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Exchange Rates
Interest Rates
Futures
Economy
Global Metrics

PDL BioPharma Total Assets 2006-2020 | PDLI

PDL BioPharma total assets from 2006 to 2020. Total assets can be defined as the sum of all assets on a company's balance sheet.
  
PDL BioPharma Annual Total Assets
(Millions of US $)
2019 $716
2018 $964
2017 $1,243
2016 $1,215
2015 $1,012
2014 $962
2013 $544
2012 $280
2011 $269
2010 $317
2009 $338
2008 $191
2007 $1,192
2006 $1,142
2005 $1,163
PDL BioPharma Quarterly Total Assets
(Millions of US $)
2020-06-30 $521
2020-03-31 $660
2019-12-31 $717
2019-09-30 $865
2019-06-30 $890
2019-03-31 $924
2018-12-31 $964
2018-09-30 $984
2018-06-30 $946
2018-03-31 $1,100
2017-12-31 $1,243
2017-09-30 $1,224
2017-06-30 $1,302
2017-03-31 $1,238
2016-12-31 $1,215
2016-09-30 $1,216
2016-06-30 $1,049
2016-03-31 $1,055
2015-12-31 $1,012
2015-09-30 $1,021
2015-06-30 $996
2015-03-31 $1,114
2014-12-31 $962
2014-09-30 $980
2014-06-30 $916
2014-03-31 $853
2013-12-31 $544
2013-09-30 $430
2013-06-30 $401
2013-03-31 $313
2012-12-31 $280
2012-09-30 $250
2012-06-30 $260
2012-03-31 $235
2011-12-31 $269
2011-09-30 $271
2011-06-30 $284
2011-03-31 $249
2010-12-31 $317
2010-09-30 $258
2010-06-30 $272
2010-03-31 $358
2009-12-31 $338
2009-09-30 $264
2009-06-30 $218
2009-03-31 $219
2008-12-31 $191
2008-09-30 $718
2008-06-30 $654
2008-03-31 $1,118
2007-12-31 $1,192
2007-09-30 $1,163
2007-06-30 $1,184
2007-03-31 $1,121
2006-12-31 $1,142
2006-09-30 $1,197
2006-06-30 $1,180
2006-03-31 $1,173
2005-12-31 $1,163
2005-09-30 $1,177
2005-06-30 $1,055
2005-03-31 $1,049
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.248B $0.055B
Protein Design Labs Inc. is a biopharmaceutical company focused on the research, development and commercialization of novel therapies for inflammation and autoimmune diseases, acute cardiac conditions and cancer. PDL markets several biopharmaceutical products in the United States through its hospital sales force and wholly-owned subsidiary, ESP Pharma, Inc. As a leader in the development of humanized antibodies, PDL has licensed its patents to numerous pharmaceutical and biotechnology companies, some of which are now paying royalties on net sales of licensed products.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $130.693B 10.06
Amgen (AMGN) United States $126.732B 13.17
CSL (CSLLY) Australia $93.560B 0.00
Gilead Sciences (GILD) United States $73.619B 9.79
Regeneron Pharmaceuticals (REGN) United States $60.329B 23.07
Vertex Pharmaceuticals (VRTX) United States $54.266B 30.28
Illumina (ILMN) United States $45.215B 52.58
Biogen (BIIB) United States $37.587B 6.68
Seattle Genetics (SGEN) United States $33.903B 0.00
BeiGene (BGNE) Cayman Islands $27.121B 0.00
Moderna (MRNA) United States $25.940B 0.00
Alexion Pharmaceuticals (ALXN) United States $25.172B 10.49
Genmab (GMAB) Denmark $22.053B 13.91
Genmab (GNMSF) Denmark $21.028B 4.84
SINO PHARMACEUT (SBMFF) Hong Kong, SAR China $19.298B 0.00
Exact Sciences (EXAS) United States $19.182B 0.00
Incyte (INCY) United States $19.025B 0.00
BioNTech SE (BNTX) Germany $17.544B 0.00
Bio-Rad Laboratories (BIO.B) United States $17.079B 77.25
Horizon Therapeutics Public (HZNP) Ireland $15.951B 37.32
Alnylam Pharmaceuticals (ALNY) United States $14.482B 0.00
BioMarin Pharmaceutical (BMRN) United States $13.491B 97.88
ARGENX SE-ADR (ARGX) Netherlands $11.956B 0.00
MyoKardia (MYOK) United States $11.809B 0.00
QIAGEN (QGEN) Netherlands $11.089B 24.97
Sarepta Therapeutics (SRPT) United States $11.017B 0.00
Guardant Health (GH) United States $10.986B 0.00
Bio-Techne Corp (TECH) United States $9.934B 68.16
Mirati Therapeutics (MRTX) United States $9.008B 0.00
Repligen (RGEN) United States $8.988B 142.67
Ascendis Pharma (ASND) Denmark $8.511B 0.00
Galapagos (GLPG) Belgium $7.880B 28.51
ACADIA Pharmaceuticals (ACAD) United States $7.320B 0.00
Adaptive Biotechnologies (ADPT) United States $6.924B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $6.646B 0.00
Exelixis (EXEL) United States $6.473B 23.54
Acceleron Pharma (XLRN) United States $6.359B 0.00
Ultragenyx Pharmaceutical (RARE) United States $5.799B 0.00
Blueprint Medicines (BPMC) United States $5.783B 0.00
SWEDISH ORP BIO (BIOVF) Sweden $5.454B 14.90
Novavax (NVAX) United States $4.984B 0.00
Denali Therapeutics (DNLI) United States $4.890B 0.00
Emergent Biosolutions (EBS) United States $4.830B 19.13
Arena Pharmaceuticals (ARNA) United States $4.808B 0.00
Amicus Therapeutics (FOLD) United States $4.725B 0.00
China Biologic Products (CBPO) China $4.558B 27.06
NeoGenomics (NEO) United States $4.401B 1328.33
Vir Biotechnology (VIR) United States $4.204B 0.00
Halozyme Therapeutics (HALO) United States $3.964B 0.00
Reata Pharmaceuticals (RETA) United States $3.928B 0.00
Fate Therapeutics (FATE) United States $3.911B 0.00
Insmed (INSM) United States $3.572B 0.00
Twist Bioscience (TWST) United States $3.553B 0.00
Bluebird Bio (BLUE) United States $3.476B 0.00
Legend Biotech (LEGN) United States $3.341B 0.00
Global Blood Therapeutics (GBT) United States $3.309B 0.00
Deciphera Pharmaceuticals (DCPH) United States $3.276B 0.00
MorphoSys AG (MOR) Germany $3.264B 42.78
Eidos Therapeutics (EIDX) United States $2.779B 0.00
Alkermes (ALKS) Ireland $2.448B 51.30
PHARMA MAR SA (PHMMF) Spain $2.348B 0.00
I-Mab (IMAB) China $2.337B 0.00
Seres Therapeutics (MCRB) United States $2.220B 0.00
Editas Medicine (EDIT) United States $1.968B 0.00
Beam Therapeutics (BEAM) United States $1.868B 0.00
Sorrento Therapeutics (SRNE) United States $1.856B 0.00
Amarin (AMRN) Ireland $1.834B 0.00
Forma Therapeutics Holdings (FMTX) United States $1.832B 0.00
Inovio Pharmaceuticals (INO) United States $1.829B 0.00
Zymeworks (ZYME) Canada $1.820B 0.00
Viela Bio (VIE) United States $1.781B 0.00
UniQure (QURE) Netherlands $1.729B 0.00
Revance Therapeutics (RVNC) United States $1.717B 0.00
BAVARIAN NORDIC (BVNRY) Denmark $1.616B 18.10
Intra-Cellular Therapies (ITCI) United States $1.571B 0.00
Dicerna Pharmaceuticals (DRNA) United States $1.564B 0.00
Sangamo Therapeutics (SGMO) United States $1.526B 0.00
Intellia Therapeutics (NTLA) United States $1.433B 0.00
Ligand Pharmaceuticals (LGND) United States $1.357B 45.88
Arcus Biosciences (RCUS) United States $1.331B 0.00
Zealand Pharma (ZEAL) Denmark $1.304B 0.00
Scholar Rock Holding (SRRK) United States $1.297B 0.00
Epizyme (EPZM) United States $1.260B 0.00
Alcobra (ARCT) United States $1.241B 0.00
Coherus BioSciences (CHRS) United States $1.224B 7.14
Mesoblast (MESO) Australia $1.222B 0.00
Mersana Therapeutics (MRSN) United States $1.202B 0.00
NGM Biopharmaceuticals (NGM) United States $1.193B 0.00
Zealand Pharma (ZLDPF) Denmark $1.191B 0.00
Cytokineticsorporated (CYTK) United States $1.082B 0.00
Retrophin (RTRX) United States $1.070B 0.00
REGENXBIO (RGNX) United States $1.063B 0.00
Heska (HSKA) United States $1.058B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $1.001B 0.00
Myriad Genetics (MYGN) United States $1.000B 0.00
Genetron Holdings (GTH) China $0.977B 0.00
Castle Biosciences (CSTL) United States $0.971B 0.00
Northwest Biotherapeutics (NWBO) United States $0.965B 0.00
Intercept Pharmaceuticals (ICPT) United States $0.949B 0.00
Adverum Biotechnologies (ADVM) United States $0.928B 0.00
Athenex (ATNX) United States $0.927B 0.00
Compugen (CGEN) Israel $0.915B 0.00
Vericel (VCEL) United States $0.884B 0.00
Arvinas (ARVN) United States $0.828B 0.00
OXFORD BIOMEDCL (OXBDF) United Kingdom $0.823B 0.00
Morphic Holding (MORF) United States $0.807B 0.00
NantKwest (NK) United States $0.805B 0.00
Codexis (CDXS) United States $0.802B 0.00
AnaptysBio (ANAB) United States $0.782B 0.00
Alector (ALEC) United States $0.770B 0.00
Frequency Therapeutics (FREQ) United States $0.738B 0.00
Pliant Therapeutics (PLRX) United States $0.737B 0.00
Intrexon (PGEN) United States $0.733B 0.00
Cellectis S.A (CLLS) France $0.708B 0.00
Pharming Group (PHGUF) Netherlands $0.688B 15.71
Syndax Pharmaceuticals (SNDX) United States $0.684B 0.00
Protagonist Therapeutics (PTGX) United States $0.681B 0.00
Agenus (AGEN) United States $0.677B 0.00
MiMedx (MDXG) United States $0.644B 0.00
Sinovac Biotech (SVA) China $0.640B 43.13
Cara Therapeutics (CARA) United States $0.620B 0.00
Celldex Therapeutics (CLDX) United States $0.601B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.580B 0.00
Kadmon Holdings (KDMN) United States $0.574B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.572B 0.00
Geron (GERN) United States $0.556B 0.00
VBI Vaccines (VBIV) United States $0.555B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.551B 28.01
IVERIC Bio (ISEE) United States $0.533B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.513B 0.00
MeiraGTx Holdings (MGTX) United States $0.496B 0.00
Albireo Pharma (ALBO) United States $0.483B 0.00
Cel-Sci (CVM) United States $0.476B 0.00
Anika Therapeutics (ANIK) United States $0.474B 20.71
ZIOPHARM Oncology Inc (ZIOP) United States $0.473B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.473B 0.00
MannKind (MNKD) United States $0.461B 0.00
Sutro Biopharma (STRO) United States $0.460B 0.00
Clovis Oncology (CLVS) United States $0.459B 0.00
UROGEN PHARMA (URGN) United States $0.458B 0.00
Aquinox Pharmaceuticals (NLTX) United States $0.458B 0.00
Prothena (PRTA) Ireland $0.450B 0.00
Amryt Pharma (AMYT) United Kingdom $0.446B 0.00
Avid Bioservices (CDMO) United States $0.428B 0.00
Starpharma Holdings (SPHRY) Australia $0.411B 0.00
Dynavax Technologies (DVAX) United States $0.411B 0.00
Orchard Therapeutics (ORTX) United Kingdom $0.409B 0.00
Merus (MRUS) Netherlands $0.378B 0.00
Kala Pharmaceuticals (KALA) United States $0.373B 0.00
Puma Biotechnology (PBYI) United States $0.361B 0.00
Selecta Biosciences (SELB) United States $0.360B 0.00
Cellular Biomedicine (CBMG) United States $0.354B 0.00
Cardiff Oncology (CRDF) United States $0.346B 0.00
Cue Biopharma (CUE) United States $0.344B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.342B 0.00
Spero Therapeutics (SPRO) United States $0.341B 0.00
Precision BioSciences (DTIL) United States $0.341B 0.00
ANI Pharmaceuticals (ANIP) United States $0.336B 7.94
AC Immune SA (ACIU) Switzerland $0.336B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.332B 0.00
IBio (IBIO) United States $0.332B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.326B 0.00
Kamada (KMDA) Israel $0.322B 15.38
Athersys (ATHX) United States $0.322B 0.00
Forte Biosciences (FBRX) United States $0.321B 0.00
BioDelivery Sciences (BDSI) United States $0.318B 22.50
Trevena (TRVN) United States $0.313B 0.00
CytomX Therapeutics (CTMX) United States $0.310B 0.00
Innate Pharma S.A (IPHA) France $0.308B 0.00
Syros Pharmaceuticals (SYRS) United States $0.305B 0.00
ChromaDex (CDXC) United States $0.286B 0.00
NextCure (NXTC) United States $0.277B 0.00
Osmotica Pharmaceuticals (OSMT) United States $0.276B 0.00
WAVE Life Sciences (WVE) Singapore $0.272B 0.00
XOMA (XOMA) United States $0.265B 0.00
Affimed (AFMD) Germany $0.243B 0.00
Pluristem Therapeutics (PSTI) Israel $0.236B 0.00
Arbutus Biopharma (ABUS) United States $0.235B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.217B 0.00
TELA Bio (TELA) United States $0.211B 0.00
Dyadic (DYAI) United States $0.205B 0.00
Fortress Biotech (FBIO) United States $0.204B 0.00
HOOKIPA Pharma (HOOK) United States $0.204B 0.00
Verastem (VSTM) United States $0.195B 0.00
POXEL SA FRANCE (PXXLF) France $0.185B 0.00
Eton Pharmaceuticals (ETON) United States $0.183B 0.00
Lineage Cell Therapeutics (LCTX) United States $0.181B 0.00
Five Prime Therapeutics (FPRX) United States $0.179B 0.00
ADMA Biologics Inc (ADMA) United States $0.178B 0.00
Liquidia Technologies (LQDA) United States $0.177B 0.00
CorMedix Inc (CRMD) United States $0.160B 0.00
Aptinyx (APTX) United States $0.157B 0.00
Cerecor (CERC) United States $0.156B 0.00
DBV Technologies S.A (DBVT) France $0.152B 0.00
Biofrontera AG (BFRA) Germany $0.150B 0.00
Nicox SA (NICXF) France $0.149B 0.00
Theratechnologies (THTX) Canada $0.149B 0.00
Kindred Biosciences (KIN) United States $0.148B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.146B 0.00
GENFIT S.A (GNFT) France $0.146B 0.00
VolitionRX (VNRX) United States $0.143B 0.00
Bellus Health (BLU) Canada $0.143B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.142B 0.00
Checkpoint Therapeutics (CKPT) United States $0.140B 0.00
Applied Genetic Technologies (AGTC) United States $0.133B 0.00
Exicure (XCUR) United States $0.132B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.131B 6.10
AquaBounty Technologies (AQB) United States $0.128B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.126B 0.00
Unum Therapeutics (COGT) United States $0.125B 0.00
Catalyst Biosciences (CBIO) United States $0.125B 0.00
SESEN BIO, INC (SESN) United States $0.123B 0.00
Prometic Life Sciences (LMNL) Canada $0.121B 0.00
Aytu Bioscience (AYTU) United States $0.120B 0.00
Cidara Therapeutics (CDTX) United States $0.119B 0.00
Lumos Pharma (LUMO) United States $0.119B 0.00
Protalix BioTherapeutics (PLX) Israel $0.115B 0.00
Windtree Therapeutics (WINT) United States $0.111B 0.00
VTv Therapeutics (VTVT) United States $0.106B 0.00
Celyad SA (CYAD) Belgium $0.106B 0.00
Strongbridge Biopharma (SBBP) United States $0.104B 0.00
Gritstone Oncology (GRTS) United States $0.104B 0.00
Orgenesis (ORGS) United States $0.099B 5.02
Idera Pharmaceuticals (IDRA) United States $0.095B 0.00
Oncobiologics (OTLK) United States $0.094B 0.00
Antibe Therapeutics (ATBPF) Canada $0.094B 0.00
Abeona Therapeutics (ABEO) United States $0.092B 0.00
AIT Therapeutics (XAIR) United States $0.090B 0.00
Enzo Biochem (ENZ) United States $0.089B 0.00
Palatin Technologies (PTN) United States $0.088B 0.00
Ecology Coatings (ABVC) United States $0.085B 0.00
PhaseBio Pharaceuticals (PHAS) United States $0.080B 0.00
DiaMedica Therapeutics (DMAC) United States $0.078B 0.00
Cyclerion Therapeutics (CYCN) United States $0.076B 0.00
ARAVIVE, INC (ARAV) United States $0.075B 0.00
Evogene (EVGN) Israel $0.074B 0.00
Stealth BioTherapeutics (MITO) United States $0.072B 69.50
Signal Genetics (MGEN) United States $0.071B 0.00
Bionano Genomics (BNGO) United States $0.070B 0.00
Prima BioMed (IMMP) Australia $0.068B 0.00
Adocia (ADOCY) France $0.067B 0.00
Synlogic (SYBX) United States $0.064B 0.00
Clearside Biomedical (CLSD) United States $0.064B 0.00
Organovo Holdings (ONVO) United States $0.062B 0.00
Curis (CRIS) United States $0.059B 0.00
Appili Therapeutics (APLIF) Canada $0.058B 0.00
Edesa Biotech (EDSA) Canada $0.057B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.057B 0.00
AmpliPhi Biosciences (ARMP) United States $0.056B 0.00
TRACON Pharmaceuticals (TCON) United States $0.055B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.055B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.054B 0.00
Proteostasis Therapeutics (PTI) United States $0.053B 0.00
Biorestorative Therapies (BRTXQ) United States $0.052B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.051B 0.00
Soligenix (SNGX) United States $0.051B 0.00
Vascular Biogenics (VBLT) Israel $0.049B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.048B 0.00
Cocrystal Pharma (COCP) United States $0.044B 0.00
Genetic Technologies (GENE) Australia $0.043B 0.00
Happiness Biotech Group (HAPP) China $0.043B 0.00
Acorda Therapeutics (ACOR) United States $0.042B 0.00
Novogen (KZIA) Australia $0.041B 0.00
CollPlant Holdings (CLGN) Israel $0.040B 0.00
IMMURON (IMRN) Australia $0.040B 0.00
AnPac Bio-Medical Science (ANPC) China $0.039B 0.00
Vaccinex (VCNX) United States $0.036B 0.00
Pulmatrix (PULM) United States $0.036B 0.00
Chanticleer Holdings (SONN) United States $0.036B 0.00
Apricus Biosciences (SEEL) United States $0.033B 0.00
Cleveland BioLabs (CBLI) United States $0.032B 0.00
ATyr Pharma (LIFE) United States $0.031B 0.00
OvaScience (MLND) United States $0.028B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.027B 0.00
BioCardia (BCDA) United States $0.025B 0.00
Advaxis (ADXS) United States $0.024B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.021B 0.00
Alimera Sciences (ALIM) United States $0.021B 0.00
Prana Biotechnology (ATHE) Australia $0.021B 0.00
PLANET GREEN HOLDINGS CORP (PLAG) China $0.020B 0.00
Spherix (AIKI) United States $0.020B 0.00
Aptevo Therapeutics (APVO) United States $0.020B 0.00
Titan Pharmaceuticals (TTNP) United States $0.019B 0.00
Celsion (CLSN) United States $0.019B 0.00
AEterna Zentaris (AEZS) United States $0.018B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.016B 0.00
Cesca Therapeutics (THMO) United States $0.014B 0.00
MYOS RENS Technology (MYOS) United States $0.013B 0.00
BioPharmX (TMBR) United States $0.012B 0.00
Neuralstem (SNCA) United States $0.010B 0.00
Benitec Biopharma (BNTC) Australia $0.003B 0.00
GeoVax Labs (GOVX) United States $0.002B 0.00
Entera Bio (ENTX) Israel $0.000B 0.00
Zai Lab (ZLAB) China $0.000B 0.00